Modulator treatment for people with cystic fibrosis: moving in the right direction

Modulator treatment for people with cystic fibrosis: moving in the right direction

Bibliographic Details
Main Author:	J. Stuart Elborn
Format:	Article
Language:	English
Published:	European Respiratory Society 2020-03-01
Series:	European Respiratory Review
Online Access:	http://err.ersjournals.com/content/29/155/200051.full

Similar Items

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01)

In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis
by: Michael M Tunney, et al.
Published: (2024-03-01)

Organisms isolated from adults with Cystic Fibrosis
by: Moore John E, et al.
Published: (2004-12-01)

Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
by: Michael D. Parkins, et al.
Published: (2011-04-01)

Early detection of <it>Pseudomonas aeruginosa </it>– comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)
by: Moore John E, et al.
Published: (2004-10-01)

CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
by: Lucile Regard, et al.
Published: (2022-05-01)

Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis
by: Pinto MC, et al.
Published: (2021-07-01)

Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa.
by: Anne Bertelsen, et al.
Published: (2020-01-01)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
by: Schmidt BZ, et al.
Published: (2016-09-01)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
by: Peter G. Middleton, et al.
Published: (2023-07-01)

Survival of people with cystic fibrosis in Australia
by: Rasa Ruseckaite, et al.
Published: (2022-11-01)

Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
by: Sarah Denford, et al.
Published: (2020-09-01)

New strategies of physical activity assessment in cystic fibrosis: a pilot study
by: Daniela Savi, et al.
Published: (2020-10-01)

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
by: Michal Shteinberg, et al.
Published: (2017-03-01)

The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
by: Anthony A Fodor, et al.
Published: (2012-01-01)

Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
by: Chaudary N
Published: (2018-12-01)

Paediatric Thoracic Imaging in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulation
by: Patrick W. O’Regan, et al.
Published: (2024-02-01)

Moving in the right direction
by: Rajaendram, Rebecca
Published: (2019)

Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis
by: Danya Muilwijk, et al.
Published: (2022-11-01)

Scoring Abdominal Symptoms in People with Cystic Fibrosis
by: Harold Tabori, et al.
Published: (2024-03-01)

Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis
by: Nico Derichs
Published: (2013-03-01)

Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.
by: Gerard McCaughey, et al.
Published: (2013-01-01)

Cystic fibrosis treatment; small molecule modulators vs genetic therapy
by: Salma Aly Elmallah, et al.
Published: (2022-10-01)

The role of modulators in cystic fibrosis related diabetes
by: Lina Merjaneh, et al.
Published: (2022-03-01)

“Just Move It . . . Move It”: A Multidisciplinary Motivational Approach to Improve Physical Activity in Children With Cystic Fibrosis
by: Valérie Sputael, et al.
Published: (2023-03-01)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
by: Jessica Maetz, et al.
Published: (2021-03-01)

Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
by: Annalucia Carbone, et al.
Published: (2023-10-01)

Chronic Rhinosinusitis with Nasal Polyposis in People with Cystic Fibrosis
by: Jessa E. Miller, et al.
Published: (2023-10-01)

Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis
by: Justin D. Anderson, et al.
Published: (2023-04-01)

Lung function and microbiota diversity in cystic fibrosis
by: Leah Cuthbertson, et al.
Published: (2020-04-01)

Real-World Outcomes of Ivacaftor Treatment in People with Cystic Fibrosis: A Systematic Review
by: Jamie Duckers, et al.
Published: (2021-04-01)

The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
by: Sana Hasan, et al.
Published: (2022-09-01)

Effectiveness and Safety of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Children With Cystic Fibrosis: A Meta-Analysis
by: Qiyu Li, et al.
Published: (2022-06-01)

Modulators of CFTR protein function in the treatment of cystic fibrosis - a literature review
by: Dariusz Chojęta, et al.
Published: (2022-08-01)

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results.
by: Judy M Bradley, et al.
Published: (2014-01-01)

Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
by: Giovanna Batoni, et al.
Published: (2022-02-01)

Cystic Fibrosis in Egyptian Children: Achievements and Future Directions
by: Mona M. El Falaki, et al.
Published: (2021-01-01)

New and investigational treatments in cystic fibrosis
by: Mangala Narasimhan, et al.
Published: (2011-08-01)

Gene therapy for the treatment of cystic fibrosis
by: Burney TJ, et al.
Published: (2012-05-01)

Treatment of pulmonary exacerbations in cystic fibrosis
by: Jayesh M. Bhatt
Published: (2013-09-01)